You are here

NetraMark Holdings Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AIAI
CSE Index: 
Currency: 

NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit https://www.netramark.com/ .

 

You are here

NetraMark Holdings Inc. (AIAI)

SEDAR Information

Company Info

Address
101-1655 Dupont Street
Toronto, ON M6P 3T1
Canada
Phone
403-681-2549
Email
swapan@netramark.com
Website
https://www.netramark.com/
Listing date
Monday, June 7, 2021
Transfer Agent
Odyssey Trust Company
Email
george@netramark.com

Capitalization

Issued & Outstanding: 
66827195
Reserved for Issuance: 
16143965

Company Officers

George Achilleos, Chief Executive Officer
Swapan Kakumanu, Chief Financial Officer

Bulletins

30/01/2023

2023-0142 - Name and Symbol Change - Nurosene Health Inc. (MEND)

le 30 janvier/January 2023

Nurosene Health Inc. (MEND) has announced a name and symbol change to NetraMark Holdings Inc. (AIAI).